http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104774791-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-42 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-112 |
filingDate | 2015-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104774791-B |
titleOfInvention | A kind of S. pullonum SP9905 and its application |
abstract | The invention discloses a kind of S. pullonum SP9905, the bacterial strain has carried out preservation, depositary institution:China typical culture collection center;Address:Wuhan University;Preservation date:On October 15th, 2014;Hide numbering:CCTCC NO.M 2014478.It is used for the application for preparing live vaccine present invention also offers described S. pullonum.Vaccine produced by the present invention has the advantages of high, the lyophilized death rate of viable count is low, and product safety is reliable, and immanoprotection action can produce strong protection at the 14th day, and immune protective rate is up to 100%, and to other serotype salmonellas(Bacterium enteritidis, avian infectious bronchitis nephritis virus)Attack equally there is preferable protective capability(80%~100%). |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105031635-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105031635-A |
priorityDate | 2015-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.